Is ALVR or ORCC a better dividend investment in 2026?

ALVR currently yields 20.39% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: ALVR offers higher current income.

What is the dividend yield difference between ALVR and ORCC?

ALVR has a forward dividend yield of 20.39% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 10.60 percentage points.

Home › Compare › ALVR vs ORCC

ALVR vs ORCC: Dividend Comparison 2026

ALVR yields 20.39% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ALVR wins by $53.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ALVR

● Live price

20.39%

Share price

$9.81

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$74.8K

Annual income

$7,021.90

Full ALVR calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — ALVR vs ORCC

📍 ALVR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ALVR	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ALVR + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ALVR pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALVR

Annual income on $10K today (after 15% tax)

$1,732.93/yr

After 10yr DRIP, annual income (after tax)

$5,968.62/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, ALVR beats the other by $5,967.73/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALVR + ORCC for your $10,000?

ALVR: 50%ORCC: 50%

100% ORCC50/50100% ALVR

Portfolio after 10yr

$48.1K

Annual income

$3,511.47/yr

Blended yield

7.30%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ALVR

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-1.3

Piotroski

1/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALVR buys

ORCC buys

No recent congressional trades found for ALVR or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricALVRORCC

Forward yield	20.39% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$74.8K ✓	$21.4K
Annual income after 10y	$7,021.90 ✓	$1.04
Total dividends collected	$42.9K ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC
Analyst consensus	Buy	Buy

Year-by-year: ALVR vs ORCC ($10,000, DRIP)

Year	ALVR Portfolio	ALVR Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$12,739	$2,038.74	$11,190	$489.61	+$1.5K → ALVR
2	$16,058	$2,427.19	$12,229	$256.01	+$3.8K → ALVR
3	$20,041	$2,859.40	$13,216	$130.74	+$6.8K → ALVR
4	$24,779	$3,335.27	$14,207	$66.02	+$10.6K → ALVR
5	$30,368	$3,854.01	$15,234	$33.17	+$15.1K → ALVR
6	$36,908	$4,414.23	$16,317	$16.62	+$20.6K → ALVR
7	$44,505	$5,013.90	$17,468	$8.32	+$27.0K → ALVR
8	$53,271	$5,650.48	$18,695	$4.16	+$34.6K → ALVR
9	$63,321	$6,320.94	$20,006	$2.08	+$43.3K → ALVR
10	$74,775	$7,021.90	$21,407	$1.04	+$53.4K → ALVR

ALVR vs ORCC: Complete Analysis 2026

ALVR — Stock

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

Full ALVR Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this ALVR vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALVR vs SCHD ALVR vs JEPI ALVR vs O ALVR vs KO ALVR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.